These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20947854)

  • 21. Antiplatelet use after intracerebral hemorrhage.
    Viswanathan A; Rakich SM; Engel C; Snider R; Rosand J; Greenberg SM; Smith EE
    Neurology; 2006 Jan; 66(2):206-9. PubMed ID: 16434655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion-Weighted Imaging Lesions After Intracerebral Hemorrhage and Risk of Stroke: A MISTIE III and ATACH-2 Analysis.
    Murthy SB; Zhang C; Gupta A; Cho SM; Rivera-Lara L; Avadhani R; Gruber J; Iadecola C; Falcone GJ; Sheth KN; Qureshi AI; Goldstein JN; Hanley DF; Kamel H; Ziai WC
    Stroke; 2021 Jan; 52(2):595-602. PubMed ID: 33467877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apixaban with antiplatelet therapy after acute coronary syndrome.
    Alexander JH; Lopes RD; James S; Kilaru R; He Y; Mohan P; Bhatt DL; Goodman S; Verheugt FW; Flather M; Huber K; Liaw D; Husted SE; Lopez-Sendon J; De Caterina R; Jansky P; Darius H; Vinereanu D; Cornel JH; Cools F; Atar D; Leiva-Pons JL; Keltai M; Ogawa H; Pais P; Parkhomenko A; Ruzyllo W; Diaz R; White H; Ruda M; Geraldes M; Lawrence J; Harrington RA; Wallentin L;
    N Engl J Med; 2011 Aug; 365(8):699-708. PubMed ID: 21780946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
    Al-Shahi Salman R; Minks DP; Mitra D; Rodrigues MA; Bhatnagar P; du Plessis JC; Joshi Y; Dennis MS; Murray GD; Newby DE; Sandercock PAG; Sprigg N; Stephen J; Sudlow CLM; Werring DJ; Whiteley WN; Wardlaw JM; White PM;
    Lancet Neurol; 2019 Jul; 18(7):643-652. PubMed ID: 31129065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of secondary medical prophylaxis and clinical outcome among patients with ischemic stroke: a nationwide follow-up study.
    Palnum KH; Mehnert F; Andersen G; Ingeman A; Krog BR; Bartels PD; Johnsen SP
    Stroke; 2012 Mar; 43(3):802-7. PubMed ID: 22207506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Hematoma Volume and Risk of Subsequent Ischemic Stroke: A MISTIE III and ATACH-2 Analysis.
    Harris W; Kaiser JH; Liao V; Avadhani R; Iadecola C; Falcone GJ; Sheth KN; Qureshi AI; Goldstein JN; Awad IA; Hanley DF; Kamel H; Ziai WC; Murthy SB
    Stroke; 2024 Mar; 55(3):541-547. PubMed ID: 38299346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study.
    Weimar C; Benemann J; Terborg C; Walter U; Weber R; Diener HC;
    Cerebrovasc Dis; 2011; 32(3):283-8. PubMed ID: 21893981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin use following intracerebral hemorrhage: a decision analysis.
    Westover MB; Bianchi MT; Eckman MH; Greenberg SM
    Arch Neurol; 2011 May; 68(5):573-9. PubMed ID: 21220650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
    Nielsen PB; Larsen TB; Skjøth F; Lip GY
    JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prior intracerebral hemorrhage and white matter hyperintensity burden on recurrent stroke risk.
    Park JH; Kwon SU; Kwon HS; Heo SH
    Sci Rep; 2021 Aug; 11(1):17406. PubMed ID: 34465828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of antiplatelet drugs on recurrent stroke in patients with intracerebral hemorrhage.
    Wong YS; Tsai CF; Ong CT
    Heliyon; 2023 Nov; 9(11):e21988. PubMed ID: 38027841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid Lowering Therapy, Low-Density Lipoprotein Level and Risk of Intracerebral Hemorrhage - A Meta-Analysis.
    Judge C; Ruttledge S; Costello M; Murphy R; Loughlin E; Alvarez-Iglesias A; Ferguson J; Gorey S; Nolan A; Canavan M; O'Halloran M; O'Donnell MJ
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1703-1709. PubMed ID: 30878368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic drug uses and deep intracerebral hemorrhages in stroke patients with deep cerebral microbleeds.
    Imaizumi T; Inamura S; Kohama I; Yoshifuji K; Nomura T; Komatsu K
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):869-75. PubMed ID: 22959109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A troponin study on patients with ischemic stroke, intracerebral hemorrhage and subarachnoid hemorrhage: Type II myocardial infarction is significantly associated with stroke severity, discharge disposition and mortality.
    Alkhachroum AM; Miller B; Chami T; Tatsuoka C; Sila C
    J Clin Neurosci; 2019 Jun; 64():83-88. PubMed ID: 31014907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.
    White HD; Huang Z; Tricoci P; Van de Werf F; Wallentin L; Lokhnygina Y; Moliterno DJ; Aylward PE; Mahaffey KW; Armstrong PW
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25012288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
    Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
    Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage.
    Castello JP; Teo KC; Abramson JR; Keins S; Takahashi CE; Leung IYH; Leung WCY; Wang Y; Kourkoulis C; Pavlos Myserlis E; Warren AD; Henry J; Chan KH; Cheung RTF; Ho SL; Gurol ME; Viswanathan A; Greenberg SM; Anderson CD; Lau KK; Rosand J; Biffi A
    J Am Heart Assoc; 2022 Mar; 11(6):e024158. PubMed ID: 35253479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
    Søndergaard L; Kasner SE; Rhodes JF; Andersen G; Iversen HK; Nielsen-Kudsk JE; Settergren M; Sjöstrand C; Roine RO; Hildick-Smith D; Spence JD; Thomassen L;
    N Engl J Med; 2017 Sep; 377(11):1033-1042. PubMed ID: 28902580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantity of Cerebral Microbleeds, Antiplatelet Therapy, and Intracerebral Hemorrhage Outcomes: A Systematic Review and Meta-analysis.
    Wang DN; Hou XW; Yang BW; Lin Y; Shi JP; Wang N
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2728-37. PubMed ID: 26342996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.